Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05045950Phase 2Recruiting
Phase 2, open-label, single-arm trial in brain metastases, sponsored by Medical College of Wisconsin. Primary endpoint: Successful completion of PRDR WBRT treatment at 5 days. Started Nov 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05045950.